Biolidics' Covid-19 rapid test kit allowed to be sold in EU
Add BT as a preferred source
Vivienne Tay
Singapore
SINGAPORE-BASED cancer diagnos-tics company Biolidics on Monday said its rapid test kit for Covid-19 is allowed for sale in the European Union (EU).
This was after the test kit obtained confirmation for CE marking, a notification process to the relevant authority which allows the company to market and sell the kit in the EU. Having the CE marking confirms the test kit complies with the relevant EU product safety directives.
TRENDING NOW
On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart
Thai and Vietnamese farmers may stop planting rice because of the Iran war. Here’s why
PayPal plans job cuts as its new CEO pursues turnaround strategy
MAS, bank CEOs convene over AI cyberthreats; boards told to own risks, not leave to IT teams
